AGREEMENT AND PLAN OF MERGER BY AND AMONG: ANI PHARMACEUTICALS, INC. ANIP MERGER SUB INC. and ALIMERA SCIENCES, INC. DATED AS OF JUNE 21, 2024Merger Agreement • June 24th, 2024 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJune 24th, 2024 Company Industry JurisdictionThis Agreement and Plan of Merger (“Agreement”) is made and entered into as of June 21, 2024 (the “Agreement Date”) by and among ANI Pharmaceuticals, Inc., a Delaware corporation (“Parent”), ANIP Merger Sub INC., a Delaware corporation and wholly owned indirect subsidiary of Parent (“Merger Subsidiary”), and Alimera Sciences, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
Agreement And Plan Of Merger dated as of February 12, 2012 among Project Plasma Holdings Corporation, Project Plasma Merger Corp. and SeraCare Life Sciences, Inc.Merger Agreement • February 14th, 2012 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledFebruary 14th, 2012 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is entered into as of February 12, 2012, by and among Project Plasma Holdings Corporation, a Delaware corporation (“Parent”), Project Plasma Merger Corp., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), and SeraCare Life Sciences, Inc., a Delaware corporation (the “Company”).